• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.78%

    More On GLPG.BR

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Galapagos NV (GLPG.BR)

    -Brussels
    42.01 Down 0.70(1.64%) 8:54AM EDT
    Prev Close:42.72
    Open:42.50
    Bid:42.01 x 2300
    Ask:42.07 x 13100
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:41.53 - 42.50
    52wk Range:15.99 - 42.50
    Volume:97,575
    Avg Vol (3m):0
    Market Cap:1.25B
    P/E (ttm):38.13
    EPS (ttm):1.10
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Headlines

    » More Headlines for GLPG.BR

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-11) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Galapagos NV, a clinical stage biotech company, develops and commercializes novel medicines in Belgium, Croatia, France, and the Netherlands. Its products include GLPG0634, an orally-available selective inhibitor of Janus kinase 1, which is in Pha... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback